These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions]. Author: Nakazono N. Journal: Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839. Abstract: More than 1,000 young females were screened for rubella HI antibodies. Clinico-laboratory studies were carried out in 272 seronegative healthy adult women who received Japanese licensed rubella vaccine, TO-336 or MEQ11 vaccine. Clinical reactions were observed in 51 (29.7%) of 172 vaccinees, aged 18-30 years (mean age; 20. 8 year), who received TO-336 vaccine, whereas only 4 cases (4.0%) had clinical reactions in 100 vaccinees, aged 18-26 years (mean age; 19.1 year), who received MEQ11 vaccine. The most troublesome and common clinical reaction was arthralgia, particularly in women received TO-336 vaccine. Joint symptoms, especially the knee, hand and finger joint, were observed in 41 of 51 cases with clinical reactions after TO-336 vaccination. On the other hand, vaccinees who received TO-336 vaccine gave a more satisfactory seroconversion response than vaccinees who received MEQ11 vaccine (100% vs 97%). This difference was also reflected in the geometric mean titers (1: 58 vs 1: 31). These results suggested strongly that MEQ11 vaccine might be a more attenuated rubella vaccine than TO-336 vaccine, according to the clinical reactions and antibody response. Associations of host factors to clinical reactions were examined. There was not a significant difference of antibody response between vaccinees who developed clinical reactions and those who did not. But vaccinees with HLA-B 15 responded well and high against two rubella vaccines. There was no specific association between HLA types and clinical reactions.[Abstract] [Full Text] [Related] [New Search]